Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Dambkowski Carl. Insider active across 2 companies, notably Apogee Therapeutics, Inc.. Cumulatively, 17 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €6.8m. History available since 3 July 2024. The latest transaction was disclosed on 21 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
38,689 shares@ US$6.840.0066% mcap4.0% of flowCommon StockSEC:0000907654-26-000043:0
11,904 shares@ US$7.800.0023% mcap1.4% of flowCommon StockSEC:0000907654-26-000043:1
11,667 shares@ US$11.770.0034% mcap2.1% of flowCommon StockSEC:0000907654-26-000043:2
38,318 shares@ US$58.42670.056% mcap33.5% of flowCommon StockSEC:0000907654-26-000043:3
53,447 shares@ US$59.10360.079% mcap47.2% of flowCommon StockSEC:0000907654-26-000043:4
13,235 shares@ US$59.96690.020% mcap11.9% of flowCommon StockSEC:0000907654-26-000043:5
2,725 shares@ US$35.755.6% of flowCommon StockSEC:0001104659-25-046896:0
2,471 shares@ US$35.565.2% of flowCommon StockSEC:0001104659-25-032308:0
1,590 shares@ US$30.483.0% of flowCommon StockSEC:0001104659-25-021862:0
795 shares@ US$22.861.1% of flowCommon StockSEC:0001104659-25-010645:0
1,360 shares@ US$22.861.9% of flowCommon StockSEC:0001104659-25-000956:0
1,815 shares@ US$22.862.6% of flowCommon StockSEC:0001104659-24-128559:0
6,665 shares@ US$46.0718.9% of flowCommon StockSEC:0001104659-24-126395:0
5,326 shares@ US$58.9118.6% of flowCommon StockSEC:0001104659-24-116027:0
5,740 shares@ US$56.1618.9% of flowCommon StockSEC:0001104659-24-106367:0
6,523 shares@ US$40.4715.6% of flowCommon StockSEC:0001104659-24-087940:0
3,852 shares@ US$37.298.6% of flowCommon StockSEC:0001104659-24-078134:0